| Price | 2,056.00p on 23-04-2026 at 09:36:40 |
|---|---|
| Change | -19.00p -0.92% |
| Buy | 2,056.00p |
| Sell | 2,055.00p |
| Last Trade: | Sell 672.00 at 2,056.00p |
| Day's Volume: | 613,667 |
| Last Close: | 2,075.00p |
| Open: | 2,055.00p |
| ISIN: | GB00BN7SWP63 |
| Day's Range | 2,053.00p - 2,078.00p |
| 52wk Range: | 1,315.00p - 2,282.00p |
| Market Capitalisation: | £82.10b |
| VWAP: | 2,066.40751p |
| Shares in Issue: | 3.99b |
Glaxosmithkline (GSK) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 672 | 2,056.00p | Automatic Execution |
10:36:21 - 23-Apr-26 |
| Sell* | 20 | 2,056.00p | Automatic Execution |
10:36:21 - 23-Apr-26 |
| Sell* | 51 | 2,056.00p | Automatic Execution |
10:36:21 - 23-Apr-26 |
| Sell* | 2 | 2,056.00p | SI Trade |
10:36:18 - 23-Apr-26 |
| Unknown* | 0 | 2,058.00p | SI Trade |
10:36:09 - 23-Apr-26 |
| Buy* | 14 | 2,058.00p | SI Trade |
10:36:09 - 23-Apr-26 |
| Unknown* | 0 | 2,058.00p | SI Trade |
10:35:32 - 23-Apr-26 |
| Unknown* | 0 | 2,058.00p | SI Trade |
10:35:30 - 23-Apr-26 |
| Sell* | 1 | 2,056.00p | SI Trade |
10:35:10 - 23-Apr-26 |
| Buy* | 66 | 2,057.00p | Automatic Execution |
10:35:09 - 23-Apr-26 |
Glaxosmithkline (GSK) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 22nd Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 21st Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 20th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 20th Apr 2026 7:00 am | RNS | Blenrep approved in China for 2L+ multiple myeloma |
| 20th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 17th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 16th Apr 2026 3:30 pm | RNS | Director/PDMR Shareholding |
| 16th Apr 2026 7:00 am | RNS | Transaction in Own Shares |
| 15th Apr 2026 7:12 am | RNS | GSK completes acquisition of 35Pharma Inc. |
| 15th Apr 2026 7:00 am | RNS | Transaction in Own Shares |